Matches in Wikidata for { <http://www.wikidata.org/entity/Q63394473> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q63394473 description "clinical trial" @default.
- Q63394473 description "ensayu clínicu" @default.
- Q63394473 description "klinisch onderzoek" @default.
- Q63394473 description "клінічне випробування" @default.
- Q63394473 name "Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children" @default.
- Q63394473 type Item @default.
- Q63394473 label "Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children" @default.
- Q63394473 prefLabel "Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children" @default.
- Q63394473 P1132 Q63394473-C5C71841-CD04-4A48-BFE3-A0173967E95F @default.
- Q63394473 P1476 Q63394473-070E62BF-58B1-4998-8FFC-0913E9B01E1D @default.
- Q63394473 P17 Q63394473-561ADB07-D4FE-41E3-9F7C-015821AD4E71 @default.
- Q63394473 P2899 Q63394473-E951BFA0-E3E7-4F6C-B7F0-1481788305C7 @default.
- Q63394473 P3098 Q63394473-41D0D16A-2B72-4E34-AB51-8E5EE96882B2 @default.
- Q63394473 P31 Q63394473-4B5A75E8-4D6A-4295-BADC-F741C5BE9E77 @default.
- Q63394473 P4135 Q63394473-291BC275-281D-4AE3-8AE3-872B0A2AC892 @default.
- Q63394473 P580 Q63394473-5C7CF03F-C3E9-4A06-A027-D38822A67B3B @default.
- Q63394473 P582 Q63394473-6FBE772A-E597-4A99-8E24-65445EB47980 @default.
- Q63394473 P6099 Q63394473-3171F3FC-BD38-4C07-966F-40C824DD2A81 @default.
- Q63394473 P8363 Q63394473-CBAC7700-A168-444C-974E-A021F7A3DE18 @default.
- Q63394473 P859 Q63394473-10219D5F-1B25-4757-8247-B4862E724BFA @default.
- Q63394473 P1132 "+75" @default.
- Q63394473 P1476 "Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-attenuated Respiratory Syncytial Virus Vaccine, RSV 6120/∆NS1, Lot RSV#018A, or RSV 6120/F1/G2/∆NS1, Lot RSV#016A, Delivered as Nose Drops to RSV-seropositive Children 12 to 59 Months of Age and RSV-seronegative Infants and Children 6 to 24 Months of Age" @default.
- Q63394473 P17 Q30 @default.
- Q63394473 P2899 "+6" @default.
- Q63394473 P3098 "NCT03596801" @default.
- Q63394473 P31 Q30612 @default.
- Q63394473 P4135 "+59" @default.
- Q63394473 P580 "2018-06-25T00:00:00Z" @default.
- Q63394473 P582 "2020-04-30T00:00:00Z" @default.
- Q63394473 P6099 Q5452194 @default.
- Q63394473 P8363 Q78089383 @default.
- Q63394473 P859 Q3519875 @default.